Research Article

Magnitude of Multidrug Resistance among Bacterial Isolates from Surgical Site Infections in Two National Referral Hospitals in Asmara, Eritrea

Table 4

Multidrug resistance patterns of Gram-negative isolates among patients in surgical wards at the Halibet and the Orotta National Referral Hospital in Asmara, Eritrea, 2017.

Resistant patterns of antibacterial agents testedNo. of agentsKlebsiellaspp., N (%)Pseudomonas spp., N (%)Acinetobacter spp., N (%)Enterobacterspp., N (%)Citrobacter spp., N (%)Proteusspp., N (%)Salmonella spp., N (%)Escherichia coli, N (%)Total no. (%)

C, CIP, SXT, GN, F, TC, AMP, CEP, CFR, CFT104 (26.7)3 (30)6 (10.45)

C, CIP, SXT, F, TC, AMP, CEP, CFR, CFT, AMI101 (12.5)1 (1.49)

C, CIP, GN, F, TC, AMP, CEP, CFR, CFT91 (50)1 (10)2 (2.99)

C, CIP, SXT, GN, F, TC, Amp, CEP, CFT92 (20)2 (2.99)

C, CIP, SXT, GN, F, TC, AMP, CFR, CFT91 (12.5)1 (1.49)

C, CIP, SXT, GN, TC, AMP, CEP, CFR, CFT91 (10)1 (1.49)

C, CIP, SXT, GN, F, TC, AMP, CEP, CFR91 (12.5)1 (1.49)

C, SXT, GN, F, TC, AMP, CEP, CFR, CFT91 (10)1 (6.7)1 (10)1 (1.49)

CIP, SXT, GN, F, TC, AMP, CEP, CFR, CFT91 (6.7)1 (1.49)

CIP, SXT, GN, TC, AMP, CEP, CFR, CFT, AMI91 (6.7)1 (1.49)

C, GN, F, TC, AMP, CEP, CFR, CFT81 (6.7)1 (1.49)

C, SXT, F, TC, AMP, CEP, CFR, CFT82 (25)2 (2.99)

C, F, TC, AMP, CEP, CFR, CFT,71 (12.5)1 (1.49)

C, GN, F, TC, AMP, CEP, CFR71 (16.7)1 (1.49)

C, SXT, GN, AMP, CEP, CFR, CFT71 (10)1 (1.49)

CIP, SXT, F, AMP, CEP, CFR, CFT71 (12.5)1 (1.49)

CIP, SXT, TC, AMP, CEP, CFR, CFT71 (6.7)1 (1.49)

F, TC, TC, AMP, CEP, CFR, CFT71 (10)1 (1.49)

GN, F, TC, AMP, CEP, CFR, CFT71 (12.5)1 (6.7)2 (2.99)

SXT, F, TC, AMP, CEP, CFR, CFT71 (12.5)1 (50)2 (2.99)

SXT, GN, F, AMP, CEP, CFR, CFT71 (10)1 (6.7)1 (1.49)

C, F, AMP, CEP, CFR, CFT61 (16.7)1 (1.49)

C, SXT, F, TC, AMP, CFR61 (16.7)1 (1.49)

C, SXT, GN, AMP, CEP, CFR61 (20)1 (16.7)2 (2.99)

F, TC, AMP, CEP, CFT, CFT61 (12.5)1 (1.49)

CIP, SXT, TC, AMP, CFR52 (20)1 (1.49)

F, AMP, CEP, CFR, CFT51 (10)1 (1.49)

F, TC, AMP, CEP, CFR51 (1.49)

F, TC, AMP, CFT, AMI51 (6.7)1 (1.49)

GN, TC, AMP, CFR, AMI51 (10)1 (1.49)

C, F, T, AMP41 (12.5)1 (1.49)

F, AMP, CEP, CFR41 (10)2 (40)2 (13.3)4 (5.97)

F, AMP, CFR, AMI41 (20)1 (1.49)

F, AMP, CFR, CFT41 (10)1 (1.49)

F, T, AMP, CEP41 (1.49)

CEP, AMP, CFR31 (12.5)1 (1.49)

F, AMP, CEP31 (10)1 (6.7)1 (1.49)

F, CEP, CFR31 (12.5)2 (33.3)2 (2.99)

F, TC, AMP31 (12.5)1 (1.49)

SXT, F, AMP,31 (10)1 (20)2 (2.99)

SXT, TC, AMP31 (1.49)

F, TC22 (25)2 (2.99)

Total1082515861064

C: chloramphenicol (30 µg); CIP: ciprofloxacin (5 µg); SXT: trimethoprim-sulfamethoxazole; GN: gentamicin (30 µg); F: nitrofurantoin; TC: tetracycline; Amp: ampicillin; Cep: cefalexin; CFR: ceftazidime; CFT: ceftriaxone; Ami: amikacin. All the tests were conducted on Mueller–Hinton agar as specified by the Clinical and Laboratory Standards Institute guidelines.